Scripps Research Institute: How a New Drug Prototype Regenerates Lung Tissue
April 11, 2024
April 11, 2024
LA JOLLA, California, April 11 (TNSres) -- The Scripps Research Institute issued the following news:
* * *
A new study from Scripps Research and Calibr-Skaggs scientists provides pharmacological proof of concept for an upcoming phase 1 clinical trial.
* * *
Pulmonary diseases are a leading cause of morbidity and mortality worldwide. For many progressive lung diseases like idiopathic pulmonary fibrosis (IPF), a key issue is a low supply of new s . . .
* * *
A new study from Scripps Research and Calibr-Skaggs scientists provides pharmacological proof of concept for an upcoming phase 1 clinical trial.
* * *
Pulmonary diseases are a leading cause of morbidity and mortality worldwide. For many progressive lung diseases like idiopathic pulmonary fibrosis (IPF), a key issue is a low supply of new s . . .